Ampakines enhance weak endogenous respiratory drive and alleviate apnea in perinatal rats

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 6, 2015, Pages 704-710

  Ren, Jun ^a   Ding, Xiuqing ^a   Greer, John J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Apnea of prematurity; Breathing; Caffeine; Newborn; Respiration

Indexed keywords

AMPA RECEPTOR AGONIST; AMPAKINE CX 1739; CAFFEINE; UNCLASSIFIED DRUG; NARCOTIC ANALGESIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY PLETHYSMOGRAPHY; BRAIN STEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG HALF LIFE; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; NEWBORN APNEA; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY DRIVE; SPINAL CORD; ANIMAL; APNEA; BREATHING; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; FETUS; NEWBORN; PLETHYSMOGRAPHY; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

ANALGESICS, OPIOID; ANIMALS; ANIMALS, NEWBORN; APNEA; BRAIN STEM; CAFFEINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FETUS; IN VITRO TECHNIQUES; PLETHYSMOGRAPHY; RATS; RESPIRATION; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SPINAL CORD;

EID: 84924757399     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201410-1898OC     Document Type: Article

References (35)

1. Abu-Shaweesh JM, Martin RJ. Neonatal apnea: what's new? Pediatr Pulmonol 2008;43:937-944.
2. Millar D, Schmidt B. Controversies surrounding xanthine therapy. Semin Neonatol 2004;9:239-244.
3. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W; Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007;357:1893-1902.
4. Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, et al.; Caffeine for Apnea of Prematurity (CAP) Trial Investigators. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 2012;307:275-282.
5. Johnson PJ. Caffeine citrate therapy for apnea of prematurity. Neonatal Netw 2011;30:408-412.
6. Howell LL, Coffin VL, Spealman RD. Behavioral and physiological effects of xanthines in nonhuman primates. Psychopharmacology (Berl) 1997;129:1-14.
7. Hoecker C, Nelle M, Poeschl J, Beedgen B, Linderkamp O. Caffeine impairs cerebral and intestinal blood fl ow velocity in preterm infants. Pediatrics 2002;109:784-787.
8. Hoecker C, Nelle M, Beedgen B, Rengelshausen J, Linderkamp O. Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants. Arch Dis Child Fetal Neonatal Ed 2006;91:F61-F64.
9. Kumral A, Tuzun F, Yesilirmak DC, Duman N, Ozkan H. Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity. Acta Paediatr 2012;101:299-303.
10. Arai AC, Xia YF, Suzuki E. Modulation of AMPA receptor kinetics differentially in fluences synaptic plasticity in the hippocampus. Neuroscience 2004;123:1011-1024.
11. Lynch G. Glutamate-based therapeutic approaches: AMPAKINEs. Curr Opin Pharmacol 2006;6:82-88.
12. Greer JJ, Smith JC, Feldman JL. The role of excitatory amino acids in the generation and transmission of respiratory drive in the neonatal rat. J Physiol 1991;437:727-749.
13. Funk GD, Smith JC, Feldman JL. Generation and transmission of respiratory oscillations in medullary slices: role of excitatory amino acids. J Neurophysiol 1993;70:1497-1515.
14. Pace RW, Mackay DD, Feldman JL, Del Negro CA. Inspiratory bursts in the preBötzinger complex depend on a calcium-activated nonspecific cation current linked to glutamate receptors in neonatal mice. J Physiol 2007;582:113-125.
15. Ren J, Poon BY, Tang Y, Funk GD, Greer JJ. Ampakines alleviate respiratory depression in rats. Am J Respir Crit Care Med 2006;174:1384-1391.
16. Ren J, Ding X, Funk GD, Greer JJ. Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats. Anesthesiology 2009;110:1364-1370.
17. Ren J, Ding X, Greer JJ. Respiratory depression in rats induced by alcohol and barbiturate and rescue by ampakine CX717. J Appl Physiol 2012;113:1004-1011.
18. Ren J, Lenal F, Yang M, Ding X, Greer JJ. Co-administration of the ampakine CX717 with propofol reduces respiratory depression and fatal apneas. Anesthesiology 2013;118:1437-1445.
19. Oertel BG, Felden L, Tran PV, Bradshaw M, Angst MS, Schmidt H, Johnson S, Greer JJ, Geisslinger G, Varney MA, et al. Selective antagonism of opioid-induced respiratory depression by an AMPAKINE molecule in humans without loss of opioid analgesia. Clin Pharmacol Ther 2010;87:204-211.
20. Erenberg A, Leff RD, Haack DG, Mosdell KW, Hicks GM, Wynne BA. Caffeine citrate for the treatment of apnea of prematurity: a doubleblind, placebo-controlled study. Pharmacotherapy 2000;20:644-652.
21. Greer JJ, Smith JC, Feldman JL. Generation of respiratory and locomotor patterns by an in vitro brainstem spinal cord fetal rat preparation. J Neurophysiol 1992;67:996-999.
22. Greer JJ, Funk GD, Ballanyi K. Preparing for the first breath: prenatal maturation of respiratory neural control. J Physiol 2006;570:437-444.
23. Greer JJ. Control of breathing activity in the fetus and newborn. Compr Physiol 2012;2:1873-1888.
24. Ren J, Greer JJ. Ontogeny of rhythmic motor patterns generated in the embryonic rat spinal cord. J Neurophysiol 2003;89:1187-1195.
25. Ballanyi K. Neuromodulation of the perinatal respiratory network. Curr Neuropharmacol 2004;2:221-243.
26. Ballanyi K, Onimaru H, Homma I. Respiratory network function in the isolated brainstem-spinal cord of newborn rats. Prog Neurobiol 1999;59:583-634.
27. Greer JJ, Carter J, Al-Zubaidy ZA. Opioid depression of respiration in neonatal rats. J Physiol 1995;485:845-855.
28. Feldman JL, Del Negro C. Looking for inspiration: new perspectives on respiratory rhythm. Nat Rev Neurosci 2006;7:232-241.
29. Funk GD, Greer JJ. The rhythmic, transverse medullary slice preparation in respiratory neurobiology: contributions and caveats. Respir Physiol Neurobiol 2013;186:236-253.
30. Cattarossi L, Haxhiu-Poskurica B, Haxhiu MA, Litmanovitz I, Martin RJ, Carlo WA. Carotid bodies and ventilatory response to hypoxia in aminophylline-treated piglets. Pediatr Pulmonol 1995;20:94-100.
31. Clancy B, Finlay BL, Darlington RB, Anand KJ. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007;28:931-937.
32. Darnall RA. The role of CO(2) and central chemoreception in the control of breathing in the fetus and the neonate. Respir Physiol Neurobiol 2010;173:201-212.
33. Ren J, Ding X, Greer JJ. 5-HT1A receptor agonist Befiradol reduces fentanyl-induced respiratory depression, analgesia and sedation in rats. Anesthesiology 2015;122:422-434.
34. Lötsch J, Skarke C, Schneider A, Hummel T, Geisslinger G. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression. Clin Pharmacol Ther 2005;78:278-287.
35. Oertel BG, Schneider A, Rohrbacher M, Schmidt H, Tegeder I, Geisslinger G, Lötsch J. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans. Clin Pharmacol Ther 2007;81:59-68.